Verification evidence is still being completed.
PDF / print export
Active Biotech
Lund, Sweden
- Verified lead
- Helen Tornqvist
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Oncology, Immunology, Clinical Therapeutics, and Drug Development
- Review cycle
- May 2026
- Full address
- Scheelevagen 22, 223 63 Lund, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Active Biotech contact page confirming the Lund address.
- Editorial note
- Active Biotech is published because the official site confirms current leadership, Lund operating address, and a clear therapeutics pipeline in oncology and immunology.
Oncology, Immunology, Clinical Therapeutics, and Drug Development
Official leadership disclosure, Official Lund contact disclosure, Clinical therapeutics platform claim
Active Biotech is published because the official site confirms current leadership, Lund operating address, and a clear therapeutics pipeline in oncology and immunology.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Lund, Sweden
Active Biotech
Oncology, Immunology, Clinical Therapeutics, and Drug Development · Clinical-stage therapeutics platform
Active Biotech runs clinical therapeutics development, oncology programs, and immunology drug development in Lund, Sweden.
- Lead
- Helen Tornqvist (verified ↗)
- Address
- Scheelevagen 22, 223 63 Lund, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Clinical-stage therapeutics platform
- Capabilities
- Clinical Therapeutics Development · Oncology Programs · Immunology Drug Development
- Founded
- 1998
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Helen Tornqvist
CEO
Full addressScheelevagen 22, 223 63 Lund, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Clinical-stage therapeutics platform
Lund, Sweden. Oncology, Immunology, Clinical Therapeutics, and Drug Development. Review completed on 21 Mar 2026.
Swedish corporate and clinical-development oversight
Official leadership disclosure, Official Lund contact disclosure, Clinical therapeutics platform claim
Oncology, Immunology, Clinical Therapeutics, and Drug Development
Active Biotech is published because the official site confirms current leadership, Lund operating address, and a clear therapeutics pipeline in oncology and immunology.
Editorial note
Active Biotech is published because the official site confirms current leadership, Lund operating address, and a clear therapeutics pipeline in oncology and immunology.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Clinical Therapeutics Development
Oncology Programs
Immunology Drug Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Drug-development workflow
Clinical program infrastructure
Oncology and immunology systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Active Biotech located?
- Active Biotech operates from Scheelevagen 22, 223 63 Lund, Sweden, Lund, Sweden.
- Who runs Active Biotech?
- Active Biotech is led by Helen Tornqvist, CEO. Verified 21 Mar 2026.
- What does Active Biotech do?
- Active Biotech runs clinical therapeutics development, oncology programs, and immunology drug development in Lund, Sweden. Core capabilities: Clinical Therapeutics Development, Oncology Programs, Immunology Drug Development.
Editorial context
Related technical briefs
Briefs that name Lund as a covered market or city.